Cadian Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,955,901
| Closed | -$13.9M | – | 31 |
|
|
2020
Q1 | $13.9M | Sell |
1,955,901
-177,442
| -8% | -$1.27M | 0.69% | 22 |
|
|
2019
Q4 | $50.9M | Sell |
2,133,343
-1,533,694
| -42% | -$36.6M | 2.25% | 17 |
|
|
2019
Q3 | $98.4M | Sell |
3,667,037
-424,650
| -10% | -$11.4M | 4.68% | 10 |
|
|
2019
Q2 | $111M | Buy |
4,091,687
+116,789
| +3% | +$3.17M | 5.01% | 7 |
|
|
2019
Q1 | $138M | Sell |
3,974,898
-2,487,707
| -38% | -$86.3M | 5.38% | 6 |
|
|
2018
Q4 | $126M | Buy |
6,462,605
+2,309,210
| +56% | +$45.1M | 5.87% | 5 |
|
|
2018
Q3 | $111M | Buy |
4,153,395
+1,873,194
| +82% | +$49.9M | 5.02% | 8 |
|
|
2018
Q2 | $86.1M | Buy |
2,280,201
+1,039,257
| +84% | +$39.3M | 4.15% | 12 |
|
|
2018
Q1 | $40.5M | Sell |
1,240,944
-283,499
| -19% | -$9.26M | 2.19% | 15 |
|
|
2017
Q4 | $74.2M | Buy |
1,524,443
+357,700
| +31% | +$17.4M | 4.52% | 9 |
|
|
2017
Q3 | $63M | Buy |
1,166,743
+840,700
| +258% | +$45.4M | 2.95% | 12 |
|
|
2017
Q2 | $18.3M | Sell |
326,043
-542,357
| -62% | -$30.5M | 0.89% | 32 |
|
|
2017
Q1 | $34M | Buy |
+868,400
| New | +$34M | 1.63% | 22 |
|